High glucose activates intracellular signaling processes, including the polyol pathway and the generation of reactive oxygen species (ROS). These pathways further activate the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway in glomerular mesangial cells.
The JAK/STAT pathway responds to intracellular ROS, oxidative stress may be a major contributor to diabetes and diabetic nephropathy. [4] [5] [6] [7] The activation of JAK/STAT pathway is essential for high glucose-induced glomerular mesangial cell growth. It also contributes greatly to the production of the cytokine transforming growth factor-b1 (TGF-b1) and extracellular matrix proteins, which contribute to diabetic nephropathy. 1, 3, 8) Probucol is a drug used clinically for lowering cholesterol with anti-oxidant and anti-proliferative effects. Also, it is a potential inhibitor of DNA damage. 9, 10) Recent studies suggest that probucol may be used for the prevention of type-2 diabetes by preventing the increases in aldose reductase, and partly arrested proteinuria and disease progression in glomerulonephritis in rats. [10] [11] [12] [13] It also exerted multiple beneficial morphological effects, including reduced cardiac fibrosis and cardiac apoptosis in rat models. 14) Glomerular mesangial cells have a central role in maintaining the structure and function of the glomerular capillary tuft. High glucose-induced growth of glomerular mesangial cells is a characteristic feature of diabetes-induced renal complications. 1, 15, 16) Mesangial cells cultured under high glucose conditions produce TGF-b1, connective tissue growth factor (CTGF) and extracellular matrix molecules at a significantly faster rate than those cultured under normal glucose conditions, which is one of the basic underlying mechanisms of diabetic nephropathy and induce persistent fibrosis in vivo. [16] [17] [18] [19] To date, there have been no reports on the effect of probucol on the JAK/STAT pathway, the growth of human mesangial cells (HMCs), and the production of TGF-b1 and CTGF in HMCs. In this study, we investigated the effect of probucol on HMCs cultured under high glucose conditions, and also investigated the molecular mechanisms underlying this effect. Cell Culture Primary HMCs were seeded in 25-cm 2 tissue culture flasks in Mesangial Cell Medium under normal glucose (NG, 5.5 mmol/l glucose), high glucose (HG, 25 mmol/l glucose), or control (5.5 mmol/l glucoseϩ19.5 mmol/l mannitol) conditions. The culture medium was supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 100 mg/ml streptomycin in a 5% CO 2 atmosphere. The cell medium was changed every other day until the cells became confluent. Cells in passages 3-6 were used. The HMCs at about 70-80% confluence, were cultured in serum-free 1640 with NG for 24 h to synchronize the cell 
MATERIALS AND METHODS

Cell Line and Reagents
Cell Proliferation Measurements
To examine the antiproliferative effects of probucol, cell proliferation was measured using 3-(4,5-dimethylthiazoly1-2)-2,5-diphenyltetrazoliumbromide (MTT) assays, 7 groups were given different levels of probucol and glucose, seeded at a density of 2000 to 5000 cells/well in a 96-well flat-bottomed microplate. Medium (180 ml) was added to every well. After 44 h, 20 ml 5 mg/ml MTT was added to every well, incubated for 4 h, then the medium was replaced with 200 ml dimethyl sulfoxide, and the 96-well microplate was shaken gently. Next, the absorbance was measured at 570 nm, and these data were transformed into a variable representing the number of cells by using a curve that correlated the absorbance with number of HMCs.
RNA Extraction and RT-PCR Analysis for TGF-b b1 mRNA and CTGF mRNA Two micrograms of template were reverse transcribed using oligo(dT)18 primers in a final volume of 20 ml. Human TGF-b1 and b-actin were amplified using the following primers: TGF-b1, forward 5Ј-GCCCTG-GACACCAACTATTGC-3Ј, reverse 5Ј-AGGCTCCAAATG-TAGGGGCAGG-3Ј, yielding a 161-bp PCR product; bactin, forward 5Ј-GTGGGGCGCCCCAGGCACCA-3Ј, reverse 5Ј-CTCCTTAATGTCACGCACGATTTC-3Ј, yielding a 539-bp PCR product. Reaction conditions were 95°C for 4 min, followed by 30 cycles of 94°C for 30 s, 60.5°C for 20 s, and 72°C for 50 s. CTGF were amplified using the following primers: forward 5Ј-CTAAGACCTGTGGGATG-GGC-3Ј, reverse 5Ј-CTCAAAGATGTCATTGTCCCC-3Ј, PCR conditions were 94°C for 2 min, 35 cycles at 94°C for 30 s, 57°C for 40 s, and 72°C for 1.5 min, followed by final extension for 10 min at 72°C, yielding a 379-bp PCR product. The PCR products were subjected to 2% agarose gel electrophoresis and analyzed with a GDS-8000 Bioimaging system (UVP, upland, CA, U.S.A.) and GelWorks 1D grab it software. RNA expression was quantified by comparison with internal-control b-actin.
Western Blot Studies of JAK2/STAT, TGF-b b1 and CTGF Proteins We investigated the effect of probucol on the JAK2/STAT, including the concentration of probucol were 25 mmol/l and 50 mmol/l, and the changing effects of 50 mmol/l probucol for different times. To extract the proteins, each dish was treated for 60 min with ice-cold lysis buffer, centrifugated at 10000 g for 5 min at 4°C. The protein concentration was assessed by a bovine serum albumin (BSA) assay method. Subsequently, samples (50 mg of protein/lane) were loaded, separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) (7%), transferred to polyvinylidene difluoride (PVDF) membranes, and blocked by a 60-min incubation at room temperature (22°C) in TTBS (TBS with 0.05% Tween 20, pH 7.4) plus 5% BSA. PVDF membranes were then incubated overnight at 4°C with JAK and STAT antibodies and b-actin antibodies. After thoroughly washing, membranes were incubated for 100 min at room temperature with goat anti-rabbit immunoglobulin G horseradish peroxidase conjugate. The proteins were detected using an ECL detection system. The intensities of the bands were measured using Image J. We measured TGF-b1 and CTGF proteins in different conditions including NG, NGϩ19.5 mmol/l mannitol, HG, 25 mmol/l probucol and 50 mmol/l probucol, the methods were the same as described for testing of JAK2/STAT proteins.
Data Analysis The data are presented as meansϮS.E. Differences were evaluated using Student's t tests for paired data and ANOVA. pϽ0.05 was considered statistically significant.
RESULTS
Anti-proliferative Effect of Probucol on HMCs
As shown in Fig. 1 , the proliferation of HMCs peaked in the HG group, and it was far greater than the proliferation in the NG group (NG: 0.254Ϯ0.028 vs. HG: 0.298Ϯ0.007, pϽ0.05, nϭ3), but no effects of hyperosmolarity were seen in the control group (NG: 0.254Ϯ0.028 vs. NGϩ19.5 mmol/l mannitol: 0.261Ϯ0.024, pϾ0.05, nϭ3). The proliferation decreased with the rising level of probucol. In the HGϩ 50 mmol/l probucol group, the proliferation was decreased significantly (HGϩ50 mmol/l probucol: 0.261Ϯ0.012 vs. HG: 0.298Ϯ0.007, pϽ0.05, nϭ3). In the HGϩ75 mmol/l probucol and HGϩ100 mmol/l probucol groups, the proliferation of HMCs were over-inhibited (HGϩ75 mmol/l probucol: 0.207Ϯ0.014 vs. NG: 0.254Ϯ0.028; HGϩ100 mmol/l probucol: 0.168Ϯ0.028 vs. NG: 0.254Ϯ0.028). This result suggested that probucol inhibited the proliferation of HMCs induced by HG in a dose-dependent manner.
Probucol Reduces the Syntheses of TGF-b b1 mRNA and CTGF mRNA To investigate HMC's ability to excrete cytokine, mRNA levels of TGF-b1 and CTGF in HMCs were evaluated by RT-PCR analysis. As shown in Fig. 2A Probucol Inhibits HG-Induced Tyrosine Phosphorylation of JAK2, STAT1 and STAT3 To explore the possible mechanism for the protective effect of probucol on HMCs, we investigated the effect of probucol on JAK2/STAT phosphorylation in HMCs. In Fig. 3A , we found that exposure of cells to HG caused increased phosphorylation of JAK2, STAT1 and STAT3. However, they were both decreased with 25 mmol/l and 50 mmol/l probucol, but 50 mmol/l probucol was more effective. In addition, as indicated in Fig. 3B , regardless of the amount of stimulation time of HMCs, 50 mmol/l probucol was effective in decreasing the phosphorylation of JAK2/STAT. Total protein levels of JAK2, STAT1 and STAT3 did not change in the presence of these treatments. These results, together with all the former results, suggest that under high glucose conditions probucol protected HMCs from overproliferation, down-regulated TGFb1 mRNA and CTGF mRNA, and controlled the activation of JAK2/STAT pathway, indicating that the protective effect of probucol may be mediated by the JAK2/STAT pathway.
Effects of Probucol on the Syntheses of TGF-b b1 and CTGF Proteins
To ensure the protective effects of probucol on HMCs and to confirm that these protective effects occurred via the JAK2/STAT pathway, TGF-b1 and CTGF protein levels in HMCs were measured by Western blot. As shown in Fig. 4 , no significant differences were found between the NGϩ19.5mmol/l mannitol group and NG group, the HG-induced overexpression of CTGF was attenuated by probucol(HG: 1.099Ϯ0.025 vs. HGϩ25 mmol/l probucol: 0.893Ϯ0.067; HG: 1.099Ϯ0.025 vs. HGϩ50 mmol/l probucol: 0.825Ϯ0.049; pϽ0.01, nϭ3), the HG-induced overexpression of TGF-b1 was also attenuated by 50 mmol/l probucol (HG: 1.339Ϯ0.193 vs. HGϩ50 mmol/l probucol: 0.841Ϯ0.223; pϽ0.05, nϭ3). However, when the activation of JAK2/STAT induced by HG were controlled by probocol (as shown in Fig. 3A) , TGF-b1 and CTGF was also controlled (Fig. 4) , which coincided with the former imagination that the protective effect of probucol was mediated by the inhibition of JAK2/STAT pathway.
DISCUSSION
Our study focused on JAK2/STAT pathway and two as- pects of HMC, cell proliferation and cytokine excretion, which are improtant in diabetic nephropathy. Several recent studies have provided evidence that probucol has anti-atherosclerotic and anti-diabetic effects, 11, 13, 14, 20) but the effect of probucol on HMCs has not been demonstrated clearly. In our study, we observed that HMCs incubated in HG exhibit abnormal growth and can serve as an in vitro model of diabetic glomerulosclerosis and all of our investigations were aimed at this HMC model. 5, 17, 21, 22) Recent reports have showed that probucol has anti-proliferative effects on intimal cells and rat mesangial cells. 13, 23) We found probucol inhibited the proliferation of HMCs induced by HG in a dose-dependent manner. As TGF-b1 and CTGF are key cytokines in diabetic nephropathy and other diseases involving fibrosis, 15, 16, 19) we studied TGF-b1 and CTGF. There have been many reports about the anti-fibrotic effect of probucol, [11] [12] [13] [14] our study showed that probucol reduced the up-regulation of mRNA and protein levels of TGFb1 and CTGF induced by HG. However, there are interesting differences, probucol decreased the HMC proliferation and the syntheses of TGF-b1 and CTGF proteins induced by HG in a dose-dependent manner, but inhibited the up-regulated mRNA levels of TGF-b1 and CTGF in a manner independent of doses and 25 mmol/l of probucol was most effective. The sensitivity of MTT, Western blot and RT-PCR are different, and probucol may play roles in both before and after synthesis of mRNA, for example, as what is established is probucol is a potential inhibitor of DNA damage, which may have effects on DNA or RNA synthesis, these effects could be covered by the following effects on the protein modification process. The molecular mechanisms for the protective effects of probucol on mesangial cells under high glucose conditions are not absolutly clear, but these observations suggest that probucol may be effective in controlling HMCs proliferation and the fibrotic cytokines which are vital in diabetic nephropathy.
It has been well established that JAK/STAT pathway plays an important role in the proliferation of cells and in the production of TGF-b1 in diabetic nephropathy in vitro and in vivo, [24] [25] [26] we also confirmed this in our present investigation. However, we found that the increased phosphorylation of JAK2, STAT1 and STAT3 induced by HG was attenuated in all of the different combinations of probucol concentrations and exposure times. The proliferation of HMCs, mRNA and protein levels of TGF-b1 and CTGF were all changed with the changement of JAK/STAT pathway induced by probucol, which confirmed the protective effects of probucol occurring via the JAK2/STAT pathway.
Probucol has been the focus of many recent investigations. However, for the first time, we report that probucol attenuates the activation of JAK2/STAT pathway, protects HMCs from overproliferation, down-regulates the mRNA levels of TGFb1 and CTGF, reduces the expression of TGF-b1 and CTGF proteins induced by HG, furthermore, this protective effect of probucol on HMCs may be obtained by the attenuated activation of JAK2/STAT. Therefore, novel therapies with probucol may be effective strategies for future treatment of diabetic nephropathy. The interaction of probucol and JAK2 and STAT proteins and the role of probucol in cell proliferation and extracellular matrix deposition in in vivo conditions should be identified, and we will investigate these questions HMCs were pretreated with NG, NGϩ19.5 mmol/l mannitol, HG, HGϩ25 mmol/l probucol or HGϩ50 mmol/l probucol for 48 h. Immunoblotting of cell extracts was then performed for TGF-b1 and CTGF as described. No significant differences were found between the control (NGϩ19.5 mmol/l mannitol) group and NG group, probucol attenuated the overexpression of TGF-b1 and CTGF proteins induced by HG ( * pϽ0.05) (# pϽ0.01). TGF-b1 and CTGF were changed by probucol in the same direction with JAK2/STAT. Values are expressed as meansϮS.E. for three independent experiments. in our future studies.
